Advanced TPS Technology for Alzheimer’s and Dementia Now Available in India
A revolutionary non-invasive brain stimulation technology is bringing fresh hope to millions of Indian families battling Alzheimer’s disease and dementia. Transcranial Pulse Stimulation (TPS), an advanced neuromodulation technology that uses short ultrasound pulses to stimulate targeted brain areas, is now available in India for the first time at Solaceum in Madhapur, Hyderabad.
What is Transcranial Pulse Stimulation (TPS)?
TPS represents a groundbreaking advancement in non-invasive neuromodulation. This cutting-edge technology delivers short ultrasound pulses through the skull to precisely targeted regions of the brain, offering a potential therapeutic avenue for patients with Alzheimer’s disease and cognitive impairment.
Key Features of TPS Technology:
- Completely Non-Invasive: No surgery or electrode implantation required
- Precision Targeting: Utilizes MRI-based neuronavigation to identify and stimulate specific brain areas
- European Innovation: Developed in Europe with CE marking approval
- Emerging Clinical Evidence: Early research shows encouraging findings in cognitive and functional outcomes
Solaceum: India’s First TPS Center
Solaceum Centre for Advanced Pain Management, Neurorehabilitation & Neuromodulation has become the first and only center in India to offer TPS as a clinical service, bringing this emerging European technology to Indian patients under specialist neurological care.
The center is led by Dr. Sreekanth Vemula, a highly qualified neurologist with credentials from prestigious institutions including AIIMS and PGIMER. As Founder and Chairman of Solaceum, Dr. Vemula is spearheading the initiative to make advanced neuromodulation technologies accessible to Indian patients.
“Alzheimer’s disease and dementia remain significant challenges for patients, families and clinicians. There is a growing need to explore innovative and non-invasive approaches that may complement existing neurological care. Technologies such as TPS are generating scientific interest because of their non-invasive nature and emerging clinical evidence,” said Dr. Sreekanth Vemula.
International Expertise Comes to Hyderabad
To ensure scientific rigor and proper understanding of this technology, Solaceum recently hosted a comprehensive scientific session on TPS for neurologists and psychiatrists in Hyderabad, in partnership with Storz Medical AG, Switzerland.
The program featured Prof. Dr. Ulrich Sprick, Medical Director and Head of the Department of Dayclinics and Out-Patients at Alexius/Josef Clinic, Neuss, Germany, and Associate Professor at the Medical Faculty of the University of Düsseldorf.
Prof. Sprick shared his extensive international experience with TPS, discussing:
- Proposed mechanisms of action
- Clinical applications in neurological conditions
- Current scientific evidence and research findings
- International best practices in TPS administration
This knowledge transfer initiative provided Indian medical professionals with valuable insights into how TPS is being utilized globally and its potential role in the evolving field of non-invasive neuromodulation.
Why TPS Matters for Indian Patients
The Growing Challenge of Alzheimer’s and Dementia
Alzheimer’s disease and dementia represent one of the most significant healthcare challenges facing India’s aging population. These progressive neurological conditions affect not only patients but also place immense emotional, physical, and financial burdens on families and caregivers.
The Need for Non-Invasive Solutions
Traditional treatment approaches for Alzheimer’s have primarily focused on medication management. However, there is a growing recognition of the need for innovative, non-invasive technologies that can complement existing care and potentially improve cognitive and functional outcomes.
TPS: A Promising New Avenue
TPS offers several advantages that make it particularly attractive for the Indian healthcare landscape:
- Safety Profile: Non-invasive nature reduces risks associated with surgical interventions
- Accessibility: Outpatient-based treatment eliminates need for hospitalization
- Complementary Approach: Can be integrated with existing treatment protocols
- Patient-Centered: Personalized treatment based on individual neurological assessment
Evidence-Based Approach to Innovation
Dr. Vemula emphasizes Solaceum’s commitment to scientific evidence and appropriate patient selection:
“At Solaceum, our objective is to make contemporary neuromodulation technologies accessible to Indian patients while ensuring that their use is guided by scientific evidence, specialist assessment and appropriate patient selection.”
This evidence-based approach is crucial as the medical community continues to evaluate TPS through ongoing clinical research and long-term studies to determine its precise role in Alzheimer’s disease and other neurological disorders.
Comprehensive Care at Solaceum
Beyond TPS, Solaceum offers a comprehensive range of advanced neurological and pain management services:
Neuromodulation & Brain Stimulation:
- Transcranial Pulse Stimulation (TPS)
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- Other advanced neuromodulation approaches
Neurorehabilitation:
- Stroke rehabilitation
- Parkinson’s disease rehabilitation
- Spasticity management
- Cognitive and neurological rehabilitation
Advanced Pain Management:
- Chronic and neuropathic pain
- Sports-related injuries
- Complex Regional Pain Syndrome (CRPS)
- Joint and musculoskeletal pain
The center combines specialist neurological evaluation with contemporary technologies and multidisciplinary rehabilitation to provide personalized treatment plans focused on improving function and quality of life.
Looking Ahead: The Future of Alzheimer’s Care in India
The introduction of TPS in India marks a significant milestone in the country’s neurological care landscape. While Alzheimer’s disease remains a complex and progressive condition with no definitive cure, technologies like TPS represent hope for improved quality of life and potentially better cognitive outcomes.
As clinical research continues to evolve and long-term evidence accumulates, TPS may play an increasingly important role in the comprehensive management of Alzheimer’s disease and other cognitive disorders.
For patients and families in India who have been searching for innovative treatment options, the availability of TPS at Solaceum represents a new chapter in the fight against Alzheimer’s and dementia—one defined by hope, innovation, and the promise of better possibilities.
For Appointments and Information:
Solaceum Centre of Excellence
📍 3rd & 4th Floor, Vijaya Diagnostic Centre, Hitech City Road, Madhapur, Hyderabad 500081
📞 +91 89776 30120
[email protected]